Abstract
The rates of phosphodiesterase-promoted hydrolysis of cGMP and cAMP have been measuted in intact neuroblastoma N1E-115 cells by determining rates of18O incorporation from18O-water into the α-phosphoryls of guanine and adenine nucleotides. The basal rate of guanine nucleotide α-phosphoryl labeling ranged from 180 to 244 pmol·mg protein−1·min−1. Sodium nitroprusside (SNP) caused a sustained 3,4-fold increase in this18O-labeling rate in conjunction with 28- and 50-fold increases in cellular cGMP concentration at 3 and 6 min, respectively. This18O-labeling rate (795 pmol·mg protein−1·min−1) corresponded with the sum of the low (1.7 μM) and high (34 μM) Km phosphodiesterase activities assayable in cell lysates which exhibited a combined maximum velocity of 808 pmol·mg protein−1·min−1 to which the highK m species contributed 84%. This information and the characteristics of the profile of18O-labeled molecular species indicate that cGMP metabolism was restricted to a very discrete cellular compartment(s) of approximately 12% of the cell volume. Carbachol (1 mM) produced a transient increase (6-fold) in cellular cGMP concentration and a transient increase (90%) in the rate of18O labeling of α-GTP during the first minute of treatment which translates into 30 additional cellular pools of cGMP hydrolyzed in this period. IBMX (1 mM) produced a relatively rapid increase in cellular cGMP (3- to 5-fold) and cAMP (2-fold) concentrations and a delayed inhibition of18O labeling of guanine and adenine nucleotide α-phosphoryls without further elevation of cyclic nucleotide levels. These results indicate that besides inhibiting cyclic nucleotide hydrolysis, IBMX also imparts a time-dependent inhibitory influence on the generation of cyclic nucleotides. The data obtained show that measurement of18O labeling of guanine and adenine nucleotide α-phosphoryls combined with measurements of cyclic nucleotide steady state levels provides a means to assess the rates of cyclic nucleotide synthesis and hydrolysis within intact cells and to identify the site(s) of action of agents that alter cellular cyclic nucleotide metabolism.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Walseth, T. F., Gander, J. E., Eide, S. J., Krick, T. P., and Goldberg, N. D. 1983.18O Labeling of adenine nucleotide α-phosphoryls in platelets. J. Biol. Chem. 258:1544–1558.
Goldberg, N. D., Ames, A. III, Gander, J. E., and Walseth, T. F. 1983. Magnitude of increase in retinal cGMP metabolic flux determined by18O incorporation into nucleotide α-phosphoryls corresponds with intensity of photic stimulation. J. Biol. Chem. 258:9213–9219.
Matsuzawa, H., and Nirenberg, M. 1975. Receptor mediated shifts in cGMP and cAMP levels in neuroblastoma cells. Proc. Natl. Acad. Sci. U.S.A. 72:3472–3476.
Richelson E. 1978. Histamine H1 receptor-mediated guanosine 3′–5′-monophosphate formation by cultured mouse neuroblastoma cells. Science 201:69–71.
Saito, M., and Deguchi, T. 1979. Effects of extracellular calcium ions on the elevation of the guanosine 3′,5′-monophosphate level in neuroblastoma cells. Biochim. Biophys. Acta 586:473–480.
Honegger, P., and Richelson, E. 1976. Biochemical differentiation of mechanically dissociated mammalian brain in aggregating cell culture. Brain Res. 109:335–354.
El-Fakahany, E., and Richelson, E. 1980. Regulation of muscarinic receptor-mediated cyclic GMP synthesis by cultured mouse neuroblastoma cells. J. Neurochem. 35:941–948.
Goldberg, N. D., passonneau, J. V., and Lowry, O. H. 1966. Effect of changes in brain metabolism of the levels of citric acid cycle intermediates. J. Biol. Chem. 241:3997–4003.
Axelson, J. T., Bodley, J. W., and Walseth, T. F. 1981. A volatile liquid chromatography system for nucleotides. Anal. Biochem. 116:357–360.
Zeilig, C. E., and Goldberg, N. D. 1077. Cell-cycle-related changes of 3′,5′-cyclic GMP levels in Novikoff hepatoma cells. Proc. Natl. Acad. Sci. U.S.A. 74:1052–1056.
Walseth, T. F., and Johnson, R. A. 1979. The enzymatic preparation of α-32P-nucleoside triphosphates, cyclic32P-AMP, and cyclic32P-GMP. Biochim. Biophys. Acta 562:11–31.
DeRubertis, F. R., and Craven, P. A. 1977. Activation of hepatic guanylate cyclase by N-methyl-N′-nitro-N-nitrosoguanidine. J. Biol. Chem. 252:5804–5813.
Olianas, M. C., Onali, P., Neff, N. H., and Costa, E. 1983. Adenylate cyclase activity of synaptic membranes from rat striatum. Mol. Pharm. 23:393–398.
Sabol, S. L., and Nirenberg, M. 1979. Regulation of adenylate cyclase of neuroblastoma x glioma hybrid cells by α-adrenergic receptors. J. Biol. Chem. 254:1913–1920.
Beavo, J. A., Rogers, N. L., Crofford, O. B., Baird, C. E., Hardman, J. G., Sutherland, E. W., and Newman, E. V. 1971. Effects of phosphodiesterase inhibitors on cyclic AMP levels and on lipolysis. Ann. N. Y. Acad. Sci. 185:129–136.
Heyman, R., Ames, A. III, Walseth, T., Barad, M., Graeff, R., and Goldberg, N. 1985. Evidence that cGMP hydrolysis is causal in phototransduction. Biophys. J. 47:101a.
Duggleby, R. G. 1981. A nonlinear regression program for small computers. Anal. Biochem. 110:9–18.
Author information
Authors and Affiliations
Additional information
Special Issue dedicated to Dr. O. H. Lowry.
Rights and permissions
About this article
Cite this article
Graeff, R.M., Walseth, T.F. & Goldberg, N.D. The dynamics of cGMP metabolism in neuroblastoma N1E-115 cells determined by18O labeling of guanine nucleotide α-phosphoryls. Neurochem Res 12, 551–560 (1987). https://doi.org/10.1007/BF01000240
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01000240